Singapore markets close in 2 hours 27 minutes
Straits Times Index
3,291.32 -1.37 (-0.04%) Nikkei
38,236.07 -37.98 (-0.10%) Hang Seng
18,190.81 +427.78 (+2.41%) FTSE 100
8,121.24 -22.89 (-0.28%) Bitcoin USD
57,628.05 -1,975.63 (-3.31%) CMC Crypto 200
1,260.77 -9.97 (-0.78%)
TherapeuticsMD, Inc. (TXMD)
NasdaqGS - NasdaqGS Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 1.8800 |
| Open | 1.8900 |
| Bid | 1.6200 x 100 |
| Ask | 2.1800 x 100 |
| Day's range | 1.8535 - 1.9095 |
| 52-week range | 1.8500 - 4.7200 |
| Volume | |
| Avg. volume | 23,131 |
| Market cap | 21.739M |
| Beta (5Y monthly) | 1.04 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
TherapeuticsMD Announces Full Year 2023 Financial Results
BOCA RATON, Fla., March 29, 2024--TherapeuticsMD, Inc. ("TherapeuticsMD" or the "Company") (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the full year ended December 31, 2023.
- Business Wire
TherapeuticsMD Announces Third Quarter 2023 Financial Results
BOCA RATON, Fla., November 14, 2023--TherapeuticsMD, Inc. ("TherapeuticsMD" or the "Company") (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the third quarter ended September 30, 2023.
- Business Wire
TherapeuticsMD Announces Second Quarter 2023 Financial Results
BOCA RATON, Fla., August 14, 2023--TherapeuticsMD, Inc. ("TherapeuticsMD" or the "Company") (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the second quarter ended June 30, 2023.
© 2024 Yahoo. All rights reserved.